Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. B. Udesen, C. Porsbjerg, C. G. Westergaard, V. Backer (Copenhagen NV, Denmark). Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time. Eur Respir J 2011; 38: Suppl. 55, 4052

Member's Comments

No comment yet.

Related content which might interest you: Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008 Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Airway inflammation and airway pathophysiology in older asthmatics Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The burden of airway hyperresponsiveness on the control of asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002